Find

  • All tenders
Ireland: Tenders/Children's Health Ireland (CHI)/Supply, commissioning, maintenance and continued support of a Electroporation device for electrochemotherapy (ECT) of cutaneous, sub-cutaneous and deep seated indications for Children's Health Ireland (CHI).

Supply, commissioning, maintenance and continued support of a Electroporation device for electrochemotherapy (ECT) of cutaneous, sub-cutaneous and deep seated indications for Children's Health Ireland (CHI).

Published deadline passed

The published deadline has passed. For multi-stage competitions a later tender deadline may still apply — check the notice or portal for the current phase.

Qualification deadline
17. nov. 2025Expired
Procedure
Without prior noticeTwo stages
Agreement
Buying goods

Brief

Children's Health Ireland (CHI) intends to enter into an agreement with IGEA Clinical Biophysics Ltd for the supply, commissioning, maintenance, and continued support of an Electroporation device for electrochemotherapy (ECT) of cutaneous, sub-cutaneous, and deep-seated indications in Dublin, with a final contract value of 270,600 €. The Cliniporator Vitae system is required for Bleomycin Electrosclerotherapy (BEST) procedures to treat vascular malformations, as it is the only available system that can deliver the necessary electrical pulses at the required depth for deep-seated indications.

Result

TED
  • Number of tenders received
    0
  • Contract value
    €270,600

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at Children's Health Ireland (CHI)

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

From the notice

  • This is a voluntary ex ante transparency (VEAT) notice. This notice acknowledges that Children’s Health Ireland (CHI) proposes to contract with IGEA Clinical Biophysics Ltd for the supply, commissioning, maintenance and continued support of a Electroporation device for electrochemotherapy (ECT) of cutaneous, sub-cutaneous and deep seated indications. Bleomycin Electrosclerotherapy (BEST) is an innovative minimally invasive treatment combining the anti-cancer drug bleomycin with controlled electrical pulses to treat vascular anomalies where other approaches have failed. The electrical pulses temporarily make cell membranes more permeable, allowing the bleomycin to enter abnormal blood vessel cells more effectively. This targeted approach causes the problematic vessels to close and shrink while preserving surrounding healthy tissue. There is no available comparable electrosclerotherapy system which can deliver the required electrical pulses, at the depth required for deep seated indications. CHI at Crumlin have had a Cliniporator Vitae on trial and have successfully treated patients with vascular malformations which have failed other treatments. Before this trial, CHI patients for whom all other lines of therapy had failed had no alternative treatment available to them. Without this technology, these children face a heartbreaking cycle of failed treatments, progressive disfigurement, and the psychological trauma that accompanies visible differences during crucial developmental years. The procedure typically requires fewer sessions than traditional sclerotherapy, dramatically reduces the risk of complications such as skin necrosis or nerve damage, and achieves superior outcomes in the most challenging cases. Children experience significantly less pain and shorter recovery times compared to major surgical procedures, allowing them to return to school, sports, and normal childhood activities within days rather than months. The technique is particularly transformative for treating lesions in cosmetically or functionally critical areas where preserving normal anatomy means preserving a child’s future. To enable the implementation of BEST procedures for treatment of vascular malformations, the paediatric interventional radiology team requires the IGEA Cliniporator Vitae system. There are no technically, clinically, financially, or administratively reasonable or viable alternative or substitute solutions that could be implemented other than the Cliniporator Vitae system.

  • Contact

    robert.keogh@olhsc.ie
  • Type
    Result · Prequalification
  • Location
    Dublin
  • Main code
    Medical equipments, pharmaceuticals and personal care products
    33000000
  • 33161000Electrosurgical unit50421000Repair and maintenance services of medical equipment51415000Installation services of electrotherapy equipment

Similar active competitions

  • Azienda Ospedale-Università Padova

    Medisinsk engroshandel

    ID25P066 Fornitura di APPARECCHIATURE E MATERIALE DI CONSUMO PER ELETTROCHEMIOTERAPIA CON TECNICA DI ELETTROPORAZIONE REVERSIBILE

    L'Azienda Ospedale-Università Padova sta pianificando l'acquisizione di apparecchiature e materiale di consumo per elettrochemioterapia con tecnica di elettroporazione reversibile, inclusi elettroporatori, manipoli per elettrodi e materiale di consumo monouso. I fornitori sono invitati a indicare la possibilità di noleggio continuato o la disponibilità a fornire l'apparecchiatura in caso di necessità, con le relative offerte economiche, e a specificare eventuali differenze rispetto a quanto indicato.

    Planning€123,400
  • Azienda Ospedale-Università Padova

    Medisinsk engroshandel

    ID25P066 Fornitura di APPARECCHIATURE E MATERIALE DI CONSUMO PER ELETTROCHEMIOTERAPIA CON TECNICA DI ELETTROPORAZIONE REVERSIBILE

    L'Azienda Ospedale-Università Padova sta pianificando l'acquisizione di apparecchiature e materiale di consumo per elettrochemioterapia con tecnica di elettroporazione reversibile, inclusi elettroporatori, manipoli per elettrodi e materiale di consumo monouso. I fornitori sono invitati a indicare la possibilità di noleggio continuato o la disponibilità a fornire l'apparecchiatura in caso di necessità, con le relative offerte economiche, e a specificare eventuali differenze rispetto a quanto indicato.

    Planning€123,400
  • Sectoral Procurement Directorate

    Medisinsk engroshandel

    CT2370/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF IRREVERSIBLE ELECTROPORATION

    Malta’s Department of Contracts seeks a framework supplier for irreversible electroporation equipment, with a maximum total contract value of €739,242. The goods are to be supplied in Malta. The notice does not specify the framework’s duration or further technical requirements.

    Competition
    9. des. 2026(17 days)
    €739,242